Exertional Heat Stroke is life-threatening and requires immediate whole-body cold-water immersion to prevent multiple organ ...
After four years of inactivity, the US Food and Drug Administration (FDA) approved three novel products for hereditary angiooedema (HAE) in 2025.
Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activities VarmX shareholders to receive initial $117m upfront and further potential milestone ...
Early prediction and prevention of venous thromboembolism is crucial in high-risk populations, such as hospitalized patients with bladder cancer.
Exclusive option agreement for CSL to acquire all issued and outstanding shares of the company, dependent on Phase 3 data LEIDEN, Netherlands, September 16, 2025--(BUSINESS WIRE)--VarmX, a biotech ...
News Medical on MSN
Decoding Sepsis: Unraveling Key Signaling Pathways for Targeted Therapies
Background： Sepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and ...
Is kidney xenotransplantation an answer to the kidney organ shortage? Experts weigh in the current promise and potential medical hurdles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback